Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China · Delayed Price · Currency is CNY 12.73
+0.02 (0.16%)
Jul 30, 2026, 9:45 AM CST
SHE:002675 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,681 | 2,741 | 2,869 | 3,276 | 3,583 | 3,912 |
Revenue Growth | -7.84% | -4.46% | -12.42% | -8.58% | -8.41% | 14.42% |
Gross Profit Gross Profit Growth | 1,406 | 1,385 | 1,348 | 1,354 | 1,532 | 1,588 |
Operating Income Operating Income Growth | 380.88 | 352.17 | 282.61 | 373.77 | 551.72 | 612.99 |
Net Income Net Income Growth | 204.33 | 195.63 | 183.83 | 209.74 | 307.29 | 151.56 |
Earnings Per Share EPS Growth | 0.25 | 0.24 | 0.22 | 0.25 | 0.38 | 0.19 |
EPS Growth | 41.60% | 6.42% | -12.35% | -33.15% | 101.38% | -63.73% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
API Division API Division Growth | 1,030 | 1,255 | 1,678 | 2,061 |
Formulation Division Formulation Division Growth | 369.81 | 325.49 | 400.16 | 483.26 |
Radio Pharmaceutical Division Radio Pharmaceutical Division Growth | 1,128 | 1,012 | 1,017 | 914.9 |
Others Others Growth | 281.4 | 275.98 | 180.6 | 123.77 |
Offset of Business Segment Offset of Business Segment Growth | -68.19 | - | - | - |
Total Total Growth | 2,741 | 2,869 | 3,276 | 3,583 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 992.88 | 1,097 | 905.55 | 664.53 | 1,049 | 955.88 |
Total Debt Total Debt Growth | 858.82 | 776.32 | 899.96 | 792.23 | 683.25 | 1,049 |
Net Cash (Debt) Net Cash Growth | 134.06 | 320.83 | 5.59 | -127.7 | 365.7 | -93.39 |
Net Cash Growth | 276.05% | 5638.53% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.16 | 0.39 | 0.01 | -0.15 | 0.45 | -0.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 434.42 | 579.85 | 287.15 | 276.94 | 996.54 | 943.58 |
Capital Expenditures CapEx Growth | -361.28 | -360.82 | -456.09 | -511.95 | -389.61 | -530.16 |
Free Cash Flow Free Cash Flow Growth | 73.13 | 219.03 | -168.94 | -235 | 606.93 | 413.42 |
Free Cash Flow Growth | -50.87% | - | - | - | 46.80% | 33.20% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 52.46% | 50.52% | 46.97% | 41.34% | 42.77% | 40.59% |
Operating Margin | 14.21% | 12.85% | 9.85% | 11.41% | 15.40% | 15.67% |
Pretax Margin | 8.39% | 7.71% | 7.64% | 10.30% | 12.44% | 9.10% |
Profit Margin | 7.62% | 7.14% | 6.41% | 6.40% | 8.58% | 3.87% |
FCF Margin | 2.73% | 7.99% | -5.89% | -7.17% | 16.94% | 10.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.081 | 0.081 | 0.080 | 0.125 | 0.150 | 0.150 |
Dividend Per Share Growth | 0.78% | 0.78% | -36.00% | -16.67% | 0% | -40.00% |
Dividend Yield | 0.64% | 0.59% | 0.66% | 0.70% | 0.94% | 0.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 51.32 | 57.92 | 54.82 | 72.07 | 44.44 | 83.52 |
Forward PE | 32.18 | 35.92 | 32.62 | 35.79 | 30.39 | 28.05 |
P/FCF Ratio | 143.31 | 51.73 | - | - | 22.50 | 30.62 |
PS Ratio | 3.91 | 4.13 | 3.51 | 4.61 | 3.81 | 3.24 |